Cargando…
Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol
Ambroxol (ABX) is a mucolytic agent used for the treatment of respiratory diseases. Bioactivity has been demonstrated as an enhancement effect on lysosomal acid β-glucosidase (β-Glu) activity in Gaucher disease (GD). The positive effects observed have been attributed to a mechanism of action similar...
Autores principales: | Pantoom, Supansa, Hules, Larissa, Schöll, Christopher, Petrosyan, Andranik, Monticelli, Maria, Pospech, Jola, Cubellis, Maria Vittoria, Hermann, Andreas, Lukas, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998264/ https://www.ncbi.nlm.nih.gov/pubmed/35408914 http://dx.doi.org/10.3390/ijms23073536 |
Ejemplares similares
-
Pyrimidopteridine‐catalyzed Photo‐mediated Hydroacetoxylation
por: Petrosyan, Andranik, et al.
Publicado: (2022) -
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2020) -
Substrate binding modes and anomer selectivity of chitinase A from Vibrio harveyi
por: Suginta, Wipa, et al.
Publicado: (2009) -
1-[(Methylsulfonyl)oxy]pyridin-1-ium methanesulfonate
por: Taeufer, Tobias, et al.
Publicado: (2021) -
Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems
por: Völkner, Christin, et al.
Publicado: (2022)